华森制药：全资子公司通过高新技术企业认定

Core Viewpoint - Huason Pharmaceutical's subsidiary, Huason Inno, has been recognized as a national high-tech enterprise for the first time, which may enhance its market position and innovation capabilities [1] Group 1 - Huason Inno is a wholly-owned subsidiary of Huason Pharmaceutical [1] - The recognition is part of the third batch of national high-tech enterprises for the year 2025, as announced by the National High-tech Enterprise Recognition Management Work Leading Group [1] - The certificate number for this recognition is GR202551102448, and it is valid for three years [1]